The emerging role of left atrial strain in cardiovascular risk stratification for multiple myeloma patients undergoing carfilzomib therapy

Back

Delegates Premium Access

The emerging role of left atrial strain in cardiovascular risk stratification for multiple myeloma patients undergoing carfilzomib therapy

Session: Risk stratification for cancer therapy-related cardiovascular disease

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Speaker: Doctor A. Colomba (Candiolo, IT)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Anna Colomba

Piemonte Oncology Foundation, Candiolo (Italy)

0 follower

5 more presentations in this session

Non-uniform cardiovascular risks of tyrosine kinase inhibitors associated with inhibition of C-terminal Src kinase

Speaker: Assistant Professor Y. Chan (Hong Kong, HK)

Cardiovascular adverse events with cdk4/6 inhibitors:a meta-analysis of randomized controlled trials

Speaker: Associate Professor C. Dolladille (Caen, FR)

Machine learning modelling using cardiac magnetic resonance images to predict cancer therapy related cardiac dysfunction with external validation in HER2+ breast cancer patients

Speaker: Professor P. Thavendiranathan (Toronto, CA)

Prospective evaluation of cardiac function following anti-BCMA CAR-T therapy in multiple myeloma

Speaker: Doctor I. Sunayama (Nishinomiya, JP)

Cardiovascular safety of modern radiotherapy techniques in breast cancer

Speaker: Mr J. Saldana Garcia (Madrid, ES)

Access the full session

Risk stratification for cancer therapy-related cardiovascular disease

Speakers: Doctor A. Colomba, Assistant Professor Y. Chan, Associate Professor C. Dolladille, Professor P. Thavendiranathan, Doctor I. Sunayama...

Access

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources